AI
| Followers | 1106 |
| Posts | 279775 |
| Boards Moderated | 10 |
| Alias Born | 03/18/2011 |
Wednesday, February 25, 2015 10:07:14 AM
$PMCB ~ "All of these factors are important parameters in assessing treatment outcome in clinical trials of patients with pancreatic cancer undergoing neoadjuvant therapy (used to shrink a tumor prior to additional treatment such as surgery) and the divergence of these matters among pancreatic cancer clinical trials makes interpretation of trial results and comparisons among trials quite difficult."
http://www.cancertreatmentreviews.com/article/S0305-7372(14)00188-1/abstract
Websites: ~ http://www.PharmaCyteBiotech.com ~
News: http://finance.yahoo.com/q/h?s=PMCB+Headlines
Live Chart: http://stockcharts.com/c-sc/sc?s=PMCB&p=D&b=6&g=0&i=p48221558137
http://www.cancertreatmentreviews.com/article/S0305-7372(14)00188-1/abstract
Websites: ~ http://www.PharmaCyteBiotech.com ~
News: http://finance.yahoo.com/q/h?s=PMCB+Headlines
Live Chart: http://stockcharts.com/c-sc/sc?s=PMCB&p=D&b=6&g=0&i=p48221558137
Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
